RecruitingNot ApplicableNCT06047782

Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.


Sponsor

Centre Hospitalier Universitaire Dijon

Enrollment

100 participants

Start Date

Jan 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Atrial fibrillation is a cardiac arrhythmia most often originating in the left atrium, causing anarchic electrical activity and thus a loss of atrial contraction. This increases the risk of stroke through clot formation in the atrium, but also of heart failure. Atrial fibrillation is a major cause of stroke, accounting for more than 25% of all strokes. In addition, a quarter of ischemic strokes remain without an obvious cause at the end of hospitalization, and it is recommended that atrial fibrillation be detected intensively with long-term heart rhythm recording. Implantable loop recorders can detect 30% of atrial fibrillation cases over the 3-year battery life of these devices, after a stroke of undetermined origin. However, these devices require a small operation to implant them under the skin, and they are expensive. The hypothesis of this study is that MRI imaging of the left atrium would enable better selection of patients to receive an implantable loop recorder. MRI can quantify the proportion of the left atrium with scar tissue, which is likely to favour the onset of atrial fibrillation. If the results confirm this hypothesis, the number of patients requiring an implantable loop recorder could be reduced, and perhaps an anticoagulation strategy based on MRI data could be introduced. In addition to the usual follow-up by cardiologists and neurologists, participation in this study involves a cardiac MRI (with contrast agent) within 3 months of the stroke.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses cardiac MRI to measure the amount of scar tissue (fibrosis) in the heart's upper chambers (atria) in patients who had a stroke of unknown cause. It aims to find out whether more scar tissue predicts a higher chance of developing atrial fibrillation (an irregular heartbeat that can cause strokes). **You may be eligible if...** - You are an adult who had a cryptogenic (unexplained) ischemic stroke within the last 30 days - You are scheduled to have a small heart monitor (loop recorder) implanted to look for irregular heartbeat - You do not have a history of atrial fibrillation and are not on long-term blood thinners **You may NOT be eligible if...** - You have a pacemaker, certain metal implants, or claustrophobia preventing MRI - You are pregnant or breastfeeding - You have severe kidney disease (MRI contrast may not be safe) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCardiac MRI (with contrast agent)

Cardiac MRI with contrast agent


Locations(1)

Chu Dijon Bourgogne

Dijon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06047782


Related Trials